The global Antibody Therapy Market is expected to reach US$ 727.78 Bn in 2032, with a favorable rate of 13.2% during the forecast period. The availability of a robust antibody therapy pipeline increases the company’s chances of achieving higher market revenue. As novel medicines and pharmaceuticals for treating diseases are licensed, the market for antibody therapy is …